A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome

NCT01497145 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

MDS

Interventions

DRUG: KRN321

Sponsor

Kyowa Kirin Co., Ltd.